Cyclacel Pharmaceuticals Secures $3 Million in Series F Preferred Stock Sale

Reuters
08 Jul
<a href="https://laohu8.com/S/CYCC">Cyclacel Pharmaceuticals</a> Secures $3 Million in Series F Preferred Stock Sale

Cyclacel Pharmaceuticals, Inc., a Delaware corporation, has announced that a stockholder holding a majority of the company's voting power has taken decisive action through written consent. This stockholder, possessing approximately 51.2% of the total voting power, has executed decisions that are pivotal for the company's strategic direction. The company, based in Kuala Lumpur, Malaysia, remains committed to keeping its stakeholders informed about significant corporate actions and developments.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cyclacel Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-017979), on July 07, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10